1. Home
  2. FEAM vs ALLR Comparison

FEAM vs ALLR Comparison

Compare FEAM & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEAM
  • ALLR
  • Stock Information
  • Founded
  • FEAM 2016
  • ALLR 2004
  • Country
  • FEAM United States
  • ALLR United States
  • Employees
  • FEAM N/A
  • ALLR N/A
  • Industry
  • FEAM Major Chemicals
  • ALLR Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEAM Industrials
  • ALLR Health Care
  • Exchange
  • FEAM Nasdaq
  • ALLR Nasdaq
  • Market Cap
  • FEAM 12.8M
  • ALLR 13.3M
  • IPO Year
  • FEAM N/A
  • ALLR N/A
  • Fundamental
  • Price
  • FEAM $3.51
  • ALLR $1.00
  • Analyst Decision
  • FEAM Strong Buy
  • ALLR
  • Analyst Count
  • FEAM 2
  • ALLR 0
  • Target Price
  • FEAM $121.00
  • ALLR N/A
  • AVG Volume (30 Days)
  • FEAM 11.9K
  • ALLR 464.0K
  • Earning Date
  • FEAM 05-15-2025
  • ALLR 08-04-2025
  • Dividend Yield
  • FEAM N/A
  • ALLR N/A
  • EPS Growth
  • FEAM N/A
  • ALLR N/A
  • EPS
  • FEAM N/A
  • ALLR N/A
  • Revenue
  • FEAM N/A
  • ALLR N/A
  • Revenue This Year
  • FEAM N/A
  • ALLR N/A
  • Revenue Next Year
  • FEAM N/A
  • ALLR N/A
  • P/E Ratio
  • FEAM N/A
  • ALLR N/A
  • Revenue Growth
  • FEAM N/A
  • ALLR N/A
  • 52 Week Low
  • FEAM $2.82
  • ALLR $0.61
  • 52 Week High
  • FEAM $33.81
  • ALLR $7.45
  • Technical
  • Relative Strength Index (RSI)
  • FEAM 33.46
  • ALLR 54.51
  • Support Level
  • FEAM $3.41
  • ALLR $0.80
  • Resistance Level
  • FEAM $3.85
  • ALLR $1.09
  • Average True Range (ATR)
  • FEAM 0.28
  • ALLR 0.07
  • MACD
  • FEAM -0.06
  • ALLR 0.02
  • Stochastic Oscillator
  • FEAM 15.24
  • ALLR 63.03

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: